Innosuisse-Funded Alzheimer’s Clinical Trial with MIAMIND®
The MIAMIND® electrical neurostimulator will be evaluated in a randomized, sham-controlled clinical trial in patients with early-stage Alzheimer’s disease (AD), supported by funding from Innosuisse.
Miamind at the MEDICA medical trade fair in Düsseldorf
Miamind was there! At the world’s largest medical technology trade fair MEDICA in Düsseldorf, we showcased our innovative, personalized neurostimulator.
Where the future works: the Novartis Campus
Bottneuro Featured by Switzerland Innovation Park Basel Area: Empowering Patients and Driving Innovation from the Novartis Campus
